ECSP993167A - COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES - Google Patents
COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASESInfo
- Publication number
- ECSP993167A ECSP993167A ECSP993167A ECSP993167A EC SP993167 A ECSP993167 A EC SP993167A EC SP993167 A ECSP993167 A EC SP993167A EC SP993167 A ECSP993167 A EC SP993167A
- Authority
- EC
- Ecuador
- Prior art keywords
- composition
- allergic diseases
- treating allergic
- effective amount
- neuroquinine
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000000172 allergic effect Effects 0.000 title 1
- 208000010668 atopic eczema Diseases 0.000 title 1
- 229940124125 5 Lipoxygenase inhibitor Drugs 0.000 abstract 1
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 201000009961 allergic asthma Diseases 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica útil para el tratamiento de la rinitiis alérgica, el asma y trastornos relacionados. En una realización, la composición comprende, en combinación, una cantidad terapéuticamente efectiva de al menos un antagonista de neuroquinina, una cantidad efectiva de al menos un inhibidor de 5-lipoxigenasa.The present invention relates to a pharmaceutical composition useful for the treatment of allergic rhinitis, asthma, and related disorders. In one embodiment, the composition comprises, in combination, a therapeutically effective amount of at least one neuroquinine antagonist, an effective amount of at least one 5-lipoxygenase inhibitor.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993167 ECSP993167A (en) | 1999-10-06 | 1999-10-06 | COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993167 ECSP993167A (en) | 1999-10-06 | 1999-10-06 | COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993167A true ECSP993167A (en) | 2000-05-25 |
Family
ID=42044155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993167 ECSP993167A (en) | 1999-10-06 | 1999-10-06 | COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993167A (en) |
-
1999
- 1999-10-06 EC ECSP993167 patent/ECSP993167A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1509232E (en) | A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer`s disease | |
| SE9803710D0 (en) | Use of certain drugs for treating nerve root injury | |
| BRPI0407993B8 (en) | p38 inhibitor compounds and pharmaceutical compositions comprising the same | |
| DE60332433D1 (en) | AZOLYLAMINOAZINE AS PROTEIN KINASE INHIBITOR | |
| DE60332604D1 (en) | AZOLYLAMINOAZINE AS PROTEIN KINASE INHIBITOR | |
| WO2002038142A3 (en) | Serotonergic compositions and methods for treatment of mild cognitive impairment | |
| NO20060328L (en) | Combination of mGluR2 antagonist and ACHE inhibitor for the treatment of acute and / or chronic neurological disorders | |
| DE602004012418D1 (en) | PIPERAZINE DERIVATIVES AND METHOD OF USE | |
| PA8583501A1 (en) | PIRROLIDONE DERIVATIVES AS MAOB INHIBITORS | |
| WO2004043456A8 (en) | Cholesterol absorption inhibitors for the treatment of demyelination | |
| BRPI0411864A (en) | combination of src kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases | |
| PA8571901A1 (en) | NEW PHARMACEUTICAL COMPOSITION | |
| AR020740A1 (en) | COMPOSITION AND METHOD TO TREAT ALLERGIC DISEASES | |
| AR020741A1 (en) | COMPOSITION AND METHOD TO TREAT ALLERGIC DISEASES | |
| BG106748A (en) | Method and compositions for treating pulmonary diseases | |
| ECSP993167A (en) | COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES | |
| DK1071463T3 (en) | Process and compositions using terfenadine metabolites in combination with leukotriene inhibitors | |
| ECSP993168A (en) | COMPOSITION AND METHOD FOR TREATING ALLERGIC DISEASES | |
| DE60309465D1 (en) | TREATMENT OR PREVENTION OF UROGENITAL ATROPHY AND ITS SYMPTOMS IN WOMEN | |
| BRPI0416202A (en) | phosphodiesterase inhibitor formulations v | |
| AU2003259198A8 (en) | Method and composition for treating and preventing influenza infection and symptoms thereof | |
| BRPI0419229A (en) | thiophenopyrimidinone derivatives substituted as 17betahydroxysteroid dehydrogenase inhibitors, use and pharmaceutical composition | |
| NO20053247D0 (en) | Use of levocetirizine in the treatment of persistent allergic rhinitis. | |
| BR0314364A (en) | Use of iv pde inhibitors to treat angiogenesis | |
| WO2000054770A8 (en) | Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis |